Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera

Not Applicable

Completed

• Conditions: Laser Stimulation
• Interventions: Device: Laser stimulation

• Registration Number: NCT03757871
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

Pain management in premature infants is essential because they are exposed to repeated minor painful procedures such as screening for premature retinopathy (ROP). Acupuncture has shown its analgesic effectiveness in many studies. Laser acupuncture is a simple, fast, side-effect-free method, but no study exists on the contribution of acupuncture in the management of pain caused by the examination of the fundus in addition to conventional therapies (suction, Glucose G30%, anaesthetic eye drops) which are not sufficiently effective.

Hypothesis: Laser acupuncture is a medical device that would reduce the pain and discomfort of premature newborns when examining the fundus with a digital camera.

Detailed Description

Randomized, single-centre, randomized, double-blind, randomized, controlled clinical trial in two parallel groups, acupuncture versus placebo as an add-on to the usual analgesic strategy (Glucose G 30%/suction and administration of a drop of anesthetic eye drops). The main objective is to evaluate the contribution of acupuncture versus placebo as an add-on to the G30% glucose solution 2 minutes before the examination associated with the instillation of a drop of oxybuprocaine administered 1 minute before the start of the examination on pain assessed at the first eye fundus (FO) by the score premature infant pain profile (PIPP) measured before the start of the examination (baseline) and on 30 seconds after the examination of both eyes.

Study Timeline

• Study First Submitted: 2018-11-13
• Study First Submitted QC: 2018-11-28
• Study First Posted: 2018-11-29
• Study Start: 2019-03-26
• Status Verified: 2020-03
• Primary Completion: 2020-03-01
• Study Completion: 2020-03-01
• Last Update Submitted: 2020-04-28
• Last Update Posted: 2020-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Premature from 23+0 to 30sa+6d regardless of birth weight with 1st FO for ROP screening;
• Premature birth weights < 1250g with a 1st FO for ROP screening;
• Informed consent of the holder(s) of parental authority;
• Child benefiting from a social security system

Exclusion Criteria

• Analgesic or sedative drug treatment (benzodiazepines, morphine and related) within 48 hours of the examination.
• Known chromosomal abnormality

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Laser Stimulation	Laser stimulation	laser pen acupuncture projecting an infrared beam with a wavelength of 905nm bilaterally for 30 seconds on each point.
Placebo	Laser stimulation	The placebo group will have an application of the pen according to the same extinguished laser criteria.

Primary Outcome Measures

Name	Time	Method
score at PIPP (premature infant pain profile) ≥ 10	24 hours	Measurement of pain or discomfort defined by a PIPP score ≥ 10

Secondary Outcome Measures

Name	Time	Method
pain and discomfort	24 hours	Assess pain and discomfort (score FANS). The FANS score is a validated hetero-rating scale for assessing acute newborn pain when the face is difficult to analyse. On the 0 to 10 side, the absence of pain is defined by a score \< 3
heart rate variability	24 hours	assessment of heart rate variability (NIPE score)

Trial Locations

Locations (1)

Hôpital Robert Debré; 🇫🇷 Paris, France